AIIMS Mangalagiri has made significant strides since its inception, particularly in the realm of medical education and healthcare services. The institution began its MBBS course in 2018 with an initial intake of just 50 students. Today, it boasts a total of 748 MBBS students, with an annual intake of 125 students. Recently, AIIMS Mangalagiri celebrated a milestone by conferring degrees on 49 MBBS graduates, five MD/MS postgraduate students, and four Post-Doctoral Certificate Course students.

The hospital has also achieved remarkable operational success, completing a staggering 31 lakh outpatient department (OPD) consultations. Currently, it serves around 3,500 to 4,000 patients daily, underscoring its vital role in the healthcare landscape of Andhra Pradesh.

In a recent development, AIIMS Mangalagiri has installed a Nucleic Acid Amplification Testing (NAAT) system, a first among all AIIMS institutions in South India. This advanced system, which cost approximately ₹1.73 crore, is capable of detecting viral RNA and DNA with high sensitivity, enabling early identification of infections such as HIV, Hepatitis B, and Hepatitis C. Ahanthem Singh, a key figure in the institution, remarked, “The NAAT system enhances safety by significantly reducing the diagnostic window period.”

Union Minister Anupriya Patel emphasized the government’s commitment to the medical sector, stating, “The Union government under the leadership of Prime Minister Narendra Modi is giving utmost priority to the medical sector.” This reflects a broader initiative to safeguard the health needs of the country’s poorer populations.

As AIIMS Mangalagiri continues to grow and innovate, observers are keenly watching its impact on medical education and healthcare delivery in the region. The advancements in technology and the increasing number of graduates are expected to contribute positively to the healthcare system in Andhra Pradesh.

The post AIIMS Mangalagiri: A Milestone in Medical Education and Healthcare appeared first on crypto.

The recent study on acute respiratory distress syndrome (ARDS) subtypes has unveiled alarming mortality rates that could reshape treatment protocols. With 51% of patients in the hyperinflammatory group succumbing within 60 days, the stakes for timely diagnosis and intervention have never been higher.

Researchers have classified ARDS patients into two distinct subtypes: hyperinflammatory and hypoinflammatory. Notably, 18% of patients fell into the hyperinflammatory category, which is associated with a significantly increased risk of mortality. In stark contrast, the hypoinflammatory group had a mortality rate of only 28% over the same period.

This groundbreaking study provides prospective evidence that these subphenotypes can be identified in real-time at the bedside, a crucial advancement from previous research that relied on retrospective analyses. The ability to categorize patients swiftly allows for more tailored treatment approaches, aligning with the principles of precision medicine.

As healthcare professionals grapple with the implications of these findings, the push for a shift toward precision medicine in managing ARDS is gaining momentum. The study emphasizes the importance of recognizing the hyperinflammatory subtype early, potentially improving patient outcomes through targeted therapies.

While the research marks a significant step forward, uncertainties remain regarding the broader applicability of these findings across diverse patient populations. Details remain unconfirmed as further studies are needed to validate these results in various clinical settings.

In summary, the identification of ARDS subtypes not only highlights the urgent need for precise medical interventions but also raises critical questions about the future of patient care in respiratory distress scenarios. As the medical community continues to explore these avenues, the hope is that such insights will lead to more effective treatment strategies and improved survival rates for affected patients.

The post Test: Understanding the Impact of Acute Respiratory Distress Syndrome Subtypes on Patient Outcomes appeared first on crypto.

April 2 is recognized globally as World Autism Awareness Day, a significant occasion that aims to raise awareness about autism and advocate for better support services for individuals on the spectrum. This year, as we approach the date in 2026, the focus remains on the urgent need for improved access to timely and quality healthcare for autistic individuals, who are diagnosed at a rate of 1 in 127 people worldwide.

Autism, a lifelong neurodevelopmental condition, affects social interaction, communication, and behavior. The challenges faced by those with autism are compounded by limited access to essential support services. As awareness grows, so does the call for early identification, inclusive education, and nurturing care, which can significantly enhance the health and well-being of autistic individuals.

The World Health Organization (WHO) is actively promoting policies that foster neuroinclusive environments across various sectors. In a noteworthy development, the WHO plans to launch a caregiver well-being training program for children with developmental delays on April 27, 2026. This initiative is expected to provide vital resources for families and caregivers, further emphasizing the importance of community support in the journey of those with autism.

In a broader context, the ongoing challenges faced by the autistic community highlight systemic issues within healthcare and social services. Access to necessary resources remains a significant barrier, and advocates stress that without comprehensive support systems, the potential of autistic individuals may be stifled. The WHO’s initiatives are a step in the right direction, but they also underscore the need for sustained commitment from governments and organizations worldwide.

As we reflect on the significance of World Autism Awareness Day, it is essential to consider the reactions from various stakeholders. Advocacy groups have expressed cautious optimism regarding the WHO’s upcoming training program, viewing it as a potential game-changer for families navigating the complexities of autism. “Join us for a webinar on April 27 to mark the launch of a new WHO caregiver well-being training,” the WHO announced, inviting the public to engage in discussions about autism and support strategies.

However, the conversation around autism awareness does not exist in isolation. Recent events, such as the LPG crisis in India, have drawn attention to the broader implications of welfare design and access to essential services. The crisis, triggered by disruptions in the Strait of Hormuz, has highlighted the importance of reliable supply systems in welfare policies. A durable welfare system must go beyond mere access to ensure stability and reliability for all citizens, including those with autism.

In light of these developments, the need for public trust in institutions, including the judiciary, has been underscored. The Supreme Court of India recently intervened in a controversy regarding a Class VIII textbook, emphasizing the delicate balance between judicial authority and free speech. This situation reflects a broader societal challenge: ensuring that all voices, including those of marginalized communities, are heard and respected.

As we approach April 2, let us remember that World Autism Awareness Day is not just a day of recognition but a call to action. The journey towards a more inclusive society for individuals with autism requires collective effort, understanding, and unwavering support from all sectors of society. Together, we can work towards a future where every individual, regardless of their neurological makeup, has the opportunity to thrive.

The post 2 april: World Autism Awareness Day: A Call to Action on April 2 appeared first on crypto.

What does the recent initiative by the National Medical Commission (NMC) mean for medical students in India? The NMC has launched an online feedback system that allows undergraduate medical students to anonymously register complaints and evaluate their colleges’ infrastructure and faculty. This move aims to enhance the quality of medical education by gathering valuable insights directly from the students.

The online ‘Student Feedback Form’ is designed to collect responses on various aspects of the medical college experience, including teaching quality and facilities. According to the NMC, “The feedback aims to gather valuable anonymous feedback on various aspects of your medical college and medical education experience.” This initiative is part of a broader effort to ensure academic standards and improve the educational environment for future doctors.

In addition to the feedback system, the NMC has issued warnings to students regarding foreign medical institutes, particularly those in Uzbekistan, that do not comply with the Foreign Medical Graduate Licentiate (FMGL) regulations. These regulations stipulate a minimum of 54 months of education at a single institution and a 12-month internship at the same university. The NMC cautioned, “Students aspiring to pursue medical education abroad have been cautioned against enrolling in foreign medical colleges unauthorized medical colleges and offshore programs operating in violation of regulatory norms.” This highlights the NMC’s commitment to safeguarding the interests of students.

Another pressing issue that the NMC is addressing is the problem of unpaid stipends for MBBS interns. The Supreme Court has been hearing this matter since 2022, with the NMC identifying 60 medical colleges, including 27 private institutions, that have failed to pay stipends to their interns. The monthly stipend for some interns is reported to be around ₹2,000, a figure that many argue is insufficient for the demanding hours they work.

The NMC has taken action by imposing a penalty of ₹1 crore on seven colleges for not providing stipend payment information. The Chief Justice remarked, “Not paying stipend to young doctors putting in 16-20 hours per day was like the practice of bonded labour.” This statement underscores the seriousness of the issue and the need for accountability among medical colleges.

As the NMC continues to implement these changes, the landscape of medical education in India is poised for transformation. However, the ongoing issue of unpaid stipends raises questions about the financial treatment of interns and the overall support provided to them during their training. Details remain unconfirmed regarding how these changes will impact the current situation for interns.

The post Nmc: National Medical Commission () Takes Steps to Improve Medical Education appeared first on crypto.

The Kerala government has been advocating for the establishment of an All India Institute of Medical Sciences (AIIMS) in the state for several years. Despite multiple proposals submitted over time, the Union government has yet to approve the project, leaving many in the state concerned about their healthcare needs.

In 2025, the Kerala government identified land in Kinalur, Kozhikode, for the proposed AIIMS project, but the absence of a clear timeline for approval from the Centre has raised questions. Union Minister of State for Health and Family Welfare, Prataprao Jadhav, confirmed, “The proposal for establishing AIIMS in Kerala has not been approved,” highlighting the ongoing uncertainty surrounding the initiative.

The demand for an AIIMS in Kerala has intensified, particularly as the state Assembly elections draw near. Political figures, including Congress MPs Kodikunnil Suresh and Adoor Prakash, have voiced their concerns, emphasizing that the lack of an AIIMS is not just a healthcare issue but a significant political matter as well.

Historically, the Union Health Ministry sought ‘in-principle’ approval from the Finance Ministry in 2019 to establish an AIIMS in Kerala, yet progress has stalled since then. The Kerala government had previously identified several potential locations for the institute back in 2016, but those proposals have not materialized into action.

The absence of an AIIMS in Kerala is particularly troubling for residents who are increasingly vocal about their healthcare needs. The situation has become a focal point for political discourse, with observers noting that the issue could influence voter sentiment in the upcoming elections.

Details remain unconfirmed regarding the reasons for the delay in the approval of the AIIMS proposal. The Centre has not provided any explanations, leaving many to speculate about the factors at play.

As the political landscape evolves, it remains to be seen how this issue will unfold. Observers suggest that the demand for an AIIMS will continue to be a pressing topic, especially as healthcare remains a critical concern for the people of Kerala.

The post Aiims: The Ongoing Struggle for in Kerala appeared first on crypto.

As the world continues to grapple with the COVID-19 pandemic, a new variant known as the Cicada variant has emerged, first identified in South Africa in November 2024. This variant, classified as BA.3.2 and part of the Omicron family, has raised alarms due to its significant number of mutations.

The Cicada variant boasts over 70 mutations compared to the original Wuhan strain, with more than 50 of these located in the spike protein. This spike protein is crucial for the virus’s ability to infect human cells, making the mutations particularly concerning for health officials.

Symptoms associated with the Cicada variant include cough, extreme fatigue, runny nose, headache, sore throat, mild fever, muscle and joint pain, loss of taste or smell, night sweats, and rash. While these symptoms are similar to those of previous variants, the real-world data on the severity of illness caused by the Cicada variant remains limited.

As of now, the Cicada variant has been detected in 22 countries, including India, where health authorities are closely monitoring its spread. The first confirmed case of the Cicada variant in the United States was reported in June 2025, with three patients confirmed by January 2026, all of whom recovered.

Dr. Robert Hopkins Jr. commented on the situation, stating, “It is possible we will see Cicada become the dominant strain in the U.S., but that is by no means certain.” This uncertainty highlights the ongoing challenges faced by public health officials as they work to understand the implications of this new variant.

The CDC has emphasized the importance of monitoring the spread of BA.3.2, noting that it provides valuable information about the potential for this new SARS-CoV-2 lineage to evade immunity from previous infections or vaccinations. This aspect is particularly critical as vaccination efforts continue worldwide.

In India, the emergence of the Cicada variant underscores the need for vigilance and preparedness in the face of evolving viral threats. Health officials are urging the public to remain cautious and adhere to safety protocols to mitigate the spread of COVID-19.

As the situation develops, the focus remains on gathering more data to assess the impact of the Cicada variant. Details remain unconfirmed, but the global health community is on alert, ready to respond to any changes in the pandemic landscape.

The emergence of the Cicada variant serves as a reminder that the fight against COVID-19 is far from over. Continuous monitoring and research will be essential in navigating this new chapter of the pandemic.

The post Cicada COVID Variant in India: A New Challenge appeared first on crypto.

The Kerala government has reportedly submitted multiple proposals over the years for establishing an AIIMS. Despite these efforts, the proposal to create an All India Institute of Medical Sciences (AIIMS) in the state has not been approved by the Union government, leaving many residents concerned about their healthcare options.

In 2025, the Kerala government identified land in Kinalur, Kozhikode, for the proposed AIIMS project. However, the Centre has not provided a timeline for when the approval might come, leading to frustration among local leaders and citizens alike.

Union Minister of State for Health and Family Welfare, Prataprao Jadhav, confirmed the lack of approval, stating, “The proposal for establishing AIIMS in Kerala has not been approved.” This statement underscores the ongoing uncertainty surrounding the project.

The demand for an AIIMS in Kerala has become a political issue ahead of the state Assembly elections, with Congress MPs Kodikunnil Suresh and Adoor Prakash vocalizing the need for improved healthcare facilities. They argue that the absence of an AIIMS is a significant concern for the state’s healthcare needs.

Historically, in 2016, several potential locations for AIIMS in Kerala were identified and proposed. By 2019, the Union Health Ministry sought ‘in-principle’ approval from the Finance Ministry to move forward with the establishment of AIIMS in the state. Yet, progress has stalled since then.

The absence of an AIIMS in Kerala is not just a logistical issue; it is also a political flashpoint. Observers note that the demand for such a facility is closely tied to the state’s healthcare needs, which have been exacerbated by the ongoing challenges in the health sector.

Details remain unconfirmed regarding the reasons for the delay in approval of the AIIMS proposal, and the timeline for its eventual implementation remains unclear. As the state approaches elections, the pressure on the Union government to address this issue intensifies.

With the political landscape shifting, the future of the AIIMS proposal in Kerala hangs in the balance, leaving many to wonder what steps will be taken next to ensure that the healthcare needs of the population are met.

The post AIIMS in Kerala: A Proposal Still Awaiting Approval appeared first on crypto.

Sun Pharmaceutical Industries Limited, commonly known as Sun Pharma, has been at the forefront of advancing patient care in dermatology, particularly in the treatment of conditions such as psoriasis, alopecia areata, and acne. At the recent 2026 AAD Annual Meeting held in Denver, Colorado, the company presented a total of 14 abstracts, showcasing its ongoing commitment to innovation in these therapeutic areas.

Among the key highlights was ILUMYA, which is focused on treating moderate-to-severe plaque psoriasis and nail psoriasis. This drug has been pivotal in improving the quality of life for many patients suffering from these challenging skin conditions. Additionally, LEQSELVI, designed for severe alopecia areata treatment, has garnered attention for its potential to change the treatment landscape for this often debilitating condition.

WINLEVI, another significant product, is indicated for acne vulgaris and is part of combination therapies aimed at providing comprehensive care for patients dealing with acne. These advancements reflect Sun Pharma’s dedication to addressing the diverse needs of dermatology patients.

However, not all news was positive. The Phase II FLASH study for Fibromun did not meet its primary endpoint for progression-free survival (PFS), raising questions about the future of this treatment. In contrast, Nidlegy showed promising results, achieving complete pathological responses in 52.6% of patients in the Phase II ‘Duncan’ study, indicating its potential effectiveness.

Furthermore, the GLIOSTELLA study, which focuses on late-line glioblastoma, has completed enrollment in the U.S., marking a significant step forward in cancer treatment research. Following the withdrawal of a prior Marketing Authorization Application in 2025, a new submission for Nidlegy is currently being prepared, reflecting Sun Pharma’s resilience and commitment to bringing effective therapies to market.

Dr. Ahmad Naim, a representative from Sun Pharma, emphasized the importance of their findings, stating, “The data we are presenting at AAD underscore our commitment to advancing dermatology and immunology through meaningful science – spanning not only clinical efficacy and safety, but also how these therapies perform over time and in real-world practice.” This statement encapsulates the company’s vision for the future of dermatological treatments.

As the industry watches closely, observers expect Sun Pharma to continue its trajectory of innovation and research, potentially reshaping the landscape of dermatological care. The outcomes of these studies and the subsequent regulatory submissions will be critical in determining the next steps for the company and its product offerings.

The post Sun Pharma Makes Strides in Dermatology at AAD Annual Meeting appeared first on crypto.

The recent donation of Rs 1 crore by Chennai-based Subbarow Apparels to the Tirumala Tirupati Devasthanam (TTD) has significant implications for the organization, particularly in the context of ongoing controversies surrounding its leadership. This contribution is earmarked for the Sri Balaji Arogya Varaprasadini scheme, which aims to enhance medical facilities and acquire advanced equipment for underprivileged patients at the Sri Venkateswara Institute of Medical Sciences (SVIMS).

The cheque was officially handed over to TTD Additional Executive Officer Ch Venkaiah Chowdary, marking a notable commitment to improving healthcare services in the region. TTD has increasingly extended its role beyond spiritual services, actively supporting education, healthcare, and social welfare programs.

However, the donation comes at a time of heightened scrutiny regarding the conduct of B.R. Naidu, the TTD Chairman. Bhumana Karunakar Reddy, a prominent figure in the YSR Congress Party (YSRCP), has publicly criticized Naidu, calling for his immediate removal due to allegations of misusing VIP darshan privileges for political gain. Reddy described Naidu’s actions as “indecent and disgraceful,” further stating that they tarnish TTD’s reputation.

Reddy’s remarks highlight a growing tension within the organization, particularly as the Jubilee Hills Society elections approach on April 5. He accused Chandrababu Naidu of falsely claiming credit for initiatives while sidelining officials who contributed to the projects, exacerbating the controversy surrounding TTD’s leadership.

The FSSAI technology lab, which was initiated during the Y.S. Jagan Mohan Reddy government, also adds another layer to the ongoing discussions about TTD’s operational integrity and leadership accountability.

As TTD continues to navigate these challenges, the impact of Subbarow Apparels’ donation could play a crucial role in shaping the future of healthcare services in Tirupati. The organization’s commitment to enhancing medical facilities is commendable, but it is overshadowed by the pressing need for leadership reform.

Details remain unconfirmed regarding the potential outcomes of the ongoing controversies and whether B.R. Naidu will face any repercussions for his alleged misconduct. The situation remains fluid, with further developments expected as stakeholders respond to the unfolding events.

The post TTD Donations Spark Controversy in Tirupati appeared first on crypto.

Datta Meghe, a veteran leader of the Bharatiya Janata Party (BJP) and a significant figure in Vidarbha’s political landscape, has passed away at the age of 89. His death marks a poignant moment for many in the region, where he was not only a political stalwart but also a champion of education and healthcare.

Meghe’s political career spanned several decades, during which he served four terms as a Lok Sabha Member of Parliament and was a member of the Rajya Sabha from 2002 to 2008. His journey in politics began with the Nationalist Congress Party (NCP), which he joined when it was formed in 1999, before transitioning to the BJP in 2014. His contributions to the political fabric of Vidarbha were profound, and his passing has left a palpable void.

Born and raised in the region, Meghe was known for his commitment to improving the lives of the people in Vidarbha. He played a crucial role in establishing educational institutions that provided higher education opportunities, thereby empowering countless students. His initiatives extended to the healthcare sector as well, where he was instrumental in providing free medical treatment to the underprivileged in Sawangi Meghe.

Nitin Gadkari, a prominent BJP leader, expressed his sorrow over Meghe’s passing, referring to him as an elder brother. Gadkari stated, “With Dattabhau’s passing, the political and social spheres of Vidarbha have suffered a great loss.” He further remarked on Meghe’s generous heart and broad mind, emphasizing that such a leader would be hard to find again.

The impact of Meghe’s death is expected to resonate beyond his immediate circle. His contributions to education and healthcare have been vital in shaping the region’s development. However, his passing may also slow down cross-party coordination and dispute resolution in Vidarbha, as he was known for his ability to bridge gaps between different political factions.

Meghe is survived by his wife, two sons, two daughters, and grandchildren, who are now left to navigate the grief of losing a beloved patriarch. His legacy, however, will continue to influence the region for years to come, as many remember his dedication to public service and community welfare.

As the region mourns the loss of Datta Meghe, many are reflecting on his significant contributions. His efforts in linking politics with education and healthcare have set a benchmark for future leaders. The sentiments expressed by Gadkari resonate with many, as they acknowledge the great loss that Vidarbha has suffered with Meghe’s passing.

Details remain unconfirmed regarding the circumstances surrounding his death, but the outpouring of grief from various political circles underscores the respect and admiration he garnered throughout his life. As tributes continue to pour in, it is clear that Datta Meghe’s influence will not be forgotten, and his legacy will inspire future generations in Vidarbha and beyond.

The post Datta Meghe: A Pillar of Vidarbha Politics Passes Away appeared first on crypto.